期刊文献+

小儿先天性心脏病术后严重消化道出血的诊疗 被引量:1

Diagnosis and therapy of gastrointestinal bleeding after operation of congenital heart disease
原文传递
导出
摘要 目的总结小儿先天性心脏病术后严重消化道出血的发病规律和治疗特点。方法分析阜外医院小儿心脏中心2007年4至9月经治的17例术后合并严重消化道出血患儿的临床资料。常规的止血治疗效果不满意者,静脉持续泵入生长抑素(思他宁)和垂体后叶素。结果术后合并严重消化道出血者均为复杂心脏畸形,以右心畸形为主。大于2岁者发病率最高。应用生长抑素6例,平均剂量(0.21±0.09)mg/h,应用垂体后叶素5例,平均剂量(0.29±0.13)U/h。1例开腹手术止血。经治疗患儿消化道出血均明显好转。2例肺动脉闭锁因肺出血死亡。结论复杂心脏畸形术后易发生严重的消化道出血。诊疗及时、规范。可以减少病死率。决定预后的关键因素是心脏畸形及其对全身器官系统的影响。 Objective To sum up the characteristics of mobidities and managements of gastrointestinal bleeding after operation of congenital heart disease. Methods Seventeen postoperative patients who suffered from severe gastrointestinal hemorrhage from April to September in 2007. When traditional managements failed, Somatostatin and Hypophysin would be given intravenously. Results Severe gastrointestinal bleeding all took place on patients with complex cardiac malformation and the majority was with right heart defects, more than 2 years. Six patients were given Somatostatin and 5 Hypophysin. One patient underwent abdominal operation because of hemorrhage. The bleeding were all cured after managements. Two patients died on account of lung bleeding. Conclusion Patients with complex malformation are prone to complicate with gastrointestinal bleeding after operation of congenital heart diseare. Rational managements can enhance the survival rate, but the kinds of anomalies and organ function are crucial.
出处 《中国小儿急救医学》 CAS 2008年第4期327-328,共2页 Chinese Pediatric Emergency Medicine
基金 北京首发基金资助项目(2005-1015)
关键词 先天性心脏病 消化道出血 生长抑素 垂体后叶素 Congenital heart disease Gastrointestinal bleeding Somatostatin Hypophysin
  • 相关文献

参考文献5

二级参考文献15

  • 1张达荣,萧树东,李继强,袁济民,李文美,张丽冬,巨卫平,王少先,王瑞明,朱志仁,江绍基.奥曲肽和垂体后叶素对门脉高压血流动力学的影响[J].中华消化杂志,1995,15(2):85-88. 被引量:125
  • 2Mangl AA, Christison-Lagay ER. Torchiana DF, et al. Gastrointestinal complications in patients undergoing heart operation:An analysis of 8709 consecutive cardiac surgical patients[J]. Ann Surg, 2005,241(6) :895 - 904.
  • 3Martinsen TC, Bergh K, Waldum HL. Gastric juice: A barrier against infectious diseases [J]. Basic Clin Pharm Toxi, 2005,96(2):94 - 102.
  • 4Metz DC. Preventing the gastrointestinal consequences of stress- related mucosal disease[J]. Curt Med Res Opin,2005,21(1) : 11 - 18.
  • 5Fennerty MB. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: Rationale for the therapeutic benefits of acid suppression[J]. Crit Care Med,2002,30(6) :S351 -S355.
  • 6Fulcmula D, Jurose I, Miura S, et al. Role of platelet - activating factor(PAF) in endothelin- induced microvascular disturbance in rat stomach[J]. Intestinal Disorder, 1991,100(5 ) :211.
  • 7Steinberg KP. Stress-related mucosal disease in the critically ill patient:Risk factors and strategies to prevent stress-related bleeding in the intensive care unit [J]. Crit Care Med, 2002,30(6):S362 -S364.
  • 8Jenkins SA , Berein A. Review article : the relative effectiveness of somatostatin and octreotide therapy in pencrease disease[J]. Aliment pharmacol Ther ,1995,9 (4) :349 - 361.
  • 9Panes J, Pique JM, Bordas JM, Casadevall M, Teres J, Bosch J,Rodes J. Effect of bolus iniection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994; 20:336-341
  • 10Burak KW, Lee SS, Beck PL. Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome. Gut 2001; 49:866 - 872

共引文献52

同被引文献3

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部